SCHEMBL5322201

SCHEMBL5322201

O=C(O)C(C1CCN(C(=O)C=Cc2ccc(F)c(F)c2F)CC1)N1CCC(c2c[nH]c3ccc(O)cc23)CC1

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5263672 0.90 CCR2 (0.78) CCR2
SCHEMBL5316034 0.90 CCR2 (0.81) CCR2
SCHEMBL5947145 0.89 CCR2 (1.00) CCR2
SCHEMBL5947159 0.89 CCR2 (1.00) CCR2
SCHEMBL5317866 0.89 CCR2 (0.67) CCR2
SCHEMBL5316630 0.88 CCR2 (0.81) CCR2
SCHEMBL5315024 0.88 CCR2 (0.82) CCR2
SCHEMBL5314347 0.87 CCR2 (0.83) CCR2
SCHEMBL5946956 0.87 CCR2 (0.87) CCR2
SCHEMBL5946949 0.87 CCR2 (0.87) CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1802602-A1 SUBSTITUTED DIPIPERDINE CCR2 ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-04 EP claimed
WO-2006036527-A1 SUBSTITUTED DIPIPERDINE CCR2 ANTAGONISTS JANSSEN PHARMACEUTICA, N.V. (BE) 2006-04-06 WO claimed